Kailera Therapeutics, Inc. 8-K

What Happened
Kailera Therapeutics, Inc. announced its quarterly financial results for the quarter ended March 31, 2026 by issuing a press release on May 26, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8‑K (Item 2.02), reporting results of operations and financial condition for the period.

Key Details

• Date of disclosure: May 26, 2026.
• Reporting period: quarter ended March 31, 2026.
• Press release: furnished as Exhibit 99.1 to the Form 8‑K (Earnings Press Release dated May 26, 2026).
• Legal note: the information was furnished (not “filed”) under the Exchange Act, so it is not subject to Section 18 liability and is not incorporated by reference into other filings.
• Form 8‑K signed by Douglas Pagán, Chief Financial Officer, on behalf of the company.

Why It Matters
This filing signals that Kailera has publicly released its latest quarterly results; investors should review the attached press release for revenue, expenses, cash position, guidance (if provided), and any operational updates. The "furnished, not filed" status is a legal designation that limits certain liabilities and means the release isn’t automatically incorporated into other SEC filings.